Primary Carnitine Deficiency - A Rare Treatable Cause of Cardiomyopathy and Massive Hepatomegaly

被引:12
作者
Deswal, Shivani [1 ,2 ]
Bijarnia-Mahay, Sunita [3 ]
Manocha, Vinamr [1 ,2 ]
Hara, Keiichi [4 ]
Shigematsu, Yosuke [5 ]
Saxena, Renu [3 ]
Verma, Ishwar C. [3 ]
机构
[1] PGIMER, Dept Pediat, New Delhi, India
[2] Dr RML Hosp, New Delhi, India
[3] Sir Ganga Ram Hosp, Inst Med Genet & Genom, New Delhi, India
[4] Natl Hosp Org, Kure Med Ctr, Dept Pediat, Aoyama Cho, Kure, Hiroshima, Japan
[5] Univ Fukui, Fac Med Sci, Dept Pediat, Fukui, Japan
关键词
Carnitine; SLC22A5; Cardiomyopathy; Hepatomegaly; Novel; FAROE-ISLANDS; OCTN2; GENE; TRANSPORTER; MUTATIONS; DISEASE;
D O I
10.1007/s12098-016-2227-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Systemic primary carnitine deficiency (CDSP) is a rare autosomal recessive disorder caused by a defect in plasma membrane uptake of carnitine due to SLC22A5 gene mutations. A nine-mo-old boy presented with hypertrophic cardiomyopathy, massive hepatomegaly and jaundice. Metabolic testing revealed very low free carnitine levels. Genetic analysis using Sanger sequencing method revealed compound heterozygous mutations in SLC22A5 gene, c.1354G > A (p. Glu452Lys, previously reported) and c. 231_234del (novel frame-shift). Oral carnitine supplementation resulted in improved clinical outcome with ejection fraction to 75 % and normalization of liver size and enzymes after 3 mo.
引用
收藏
页码:83 / 85
页数:3
相关论文
共 11 条
[1]   SYSTEMIC CARNITINE DEFICIENCY - A TREATABLE INHERITED LIPID-STORAGE DISEASE PRESENTING AS REYES-SYNDROME [J].
CHAPOY, PR ;
ANGELINI, C ;
BROWN, WJ ;
STIFF, JE ;
SHUG, AL ;
CEDERBAUM, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (24) :1389-1394
[2]   Role of carnitine in disease [J].
Flanagan, Judith L. ;
Simmons, Peter A. ;
Vehige, Joseph ;
Willcox, Mark D. P. ;
Garrett, Qian .
NUTRITION & METABOLISM, 2010, 7
[3]   Primary Carnitine Deficiency and Cardiomyopathy [J].
Fu, Lijun ;
Huan, Meirong ;
Chen, Shubao .
KOREAN CIRCULATION JOURNAL, 2013, 43 (12) :785-792
[4]  
Kilic M, 2012, JIMD REP, V3, P17, DOI 10.1007/8904_2011_36
[5]   Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency [J].
Koizumi, A ;
Nozaki, J ;
Ohura, T ;
Kayo, T ;
Wada, Y ;
Nezu, J ;
Ohashi, R ;
Tamai, I ;
Shoji, Y ;
Takada, G ;
Kibira, S ;
Matsuishi, T ;
Tsuji, A .
HUMAN MOLECULAR GENETICS, 1999, 8 (12) :2247-2254
[6]   Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening [J].
Lee, Ni-Chung ;
Tang, Nelson Leung-Sang ;
Chien, Yin-Hsiu ;
Chen, Chun-An ;
Lin, Sho-Juan ;
Chiu, Pao-Chin ;
Huang, Ai-Chu ;
Hwu, Wuh-Liang .
MOLECULAR GENETICS AND METABOLISM, 2010, 100 (01) :46-50
[7]   Molecular Spectrum of SLC22A5 (OCTN2) Gene Mutations Detected in 143 Subjects Evaluated for Systemic Carnitine Deficiency [J].
Li, Fang-Yuan ;
El-Hattab, Ayman W. ;
Bawle, Erawati V. ;
Boles, Richard G. ;
Schmitt, Eric S. ;
Scaglia, Fernando ;
Wong, Lee-Jun .
HUMAN MUTATION, 2010, 31 (08) :E1632-E1651
[8]   Carnitine transporter and holocarboxylase synthetase deficiencies in the Faroe Islands [J].
Lund, A. M. ;
Joensen, F. ;
Hougaard, D. M. ;
Jensen, L. K. ;
Christensen, E. ;
Christensen, M. ;
Norgaard-Petersen, B. ;
Schwartz, M. ;
Skovby, F. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 (03) :341-349
[9]   Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management [J].
Magoulas, Pilar L. ;
El-Hattab, Ayman W. .
ORPHANET JOURNAL OF RARE DISEASES, 2012, 7
[10]   Primary carnitine deficiency as a cause of metabolic leukoencephalopathy: Report of one case [J].
Mahale, Rohan R. ;
Mehta, Anish ;
Timmappaya, A. ;
Srinivasa, Rangasetty .
NEUROLOGY INDIA, 2016, 64 (01) :166-168